NF1P1: A Drug Target / Disease Biomarker (G100419006)

Target Name: NF1P1

NCBI ID: G100419006

NF1P1

Other Name(s): neurofibromin 1 pseudogene 1 | NF1HHS | Neurofibromin 1 pseudogene 1

NF1P1: A Drug Target / Disease Biomarker

NF1P1, also known as N-fucsin, is a protein that is expressed in many tissues throughout the body, including the nervous system, endocrine system, and blood vessels. It is a key regulator of the fibroblast, a cell that is responsible for producing extracellular matrix (ECM) components, such as collagen. ECM is a complex structure that provides structural support and helps maintain tissue integrity, but it also plays a role in the development and progression of many diseases, including cancer.

One of the key functions of NF1P1 is its role in the regulation of fibrosis, which is the process by which cells become abnormally persistent and can contribute to the development and progression of diseases. Fibrosis is a complex process that involves the activation and proliferation of fibroblasts, the production of ECM components, and the recruitment of immune cells to the site of injury or damage.NF1P1 plays a key role in these processes by regulating the activity of fibroblasts and the production of ECM components.

In addition to its role in fibrosis, NF1P1 has also been shown to be involved in the regulation of cell signaling pathways that are important for many cellular processes, including cell growth, differentiation, and survival. For example, studies have shown that NF1P1 can interact with the protein TGF-β, which is a key regulator of cell signaling pathways that are involved in many cellular processes, including cell growth, differentiation, and survival.

As a drug target or biomarker, NF1P1 is of interest to researchers because of its potential role in the regulation of fibrosis and other diseases. Many diseases, including cancer, are characterized by the activation and proliferation of fibroblasts and the production of ECM components. By targeting NF1P1, researchers may be able to develop new treatments for these diseases. Additionally, the regulation of cell signaling pathways by NF1P1 may be a useful target for the development of new therapies for a wide range of diseases.

In conclusion, NF1P1 is a protein that is expressed in many tissues throughout the body and is involved in the regulation of fibrosis, cell signaling pathways, and the development and progression of many diseases. As a drug target or biomarker, it is of interest to researchers because of its potential role in the development of new treatments for a wide range of diseases. Further research is needed to fully understand the functions of NF1P1 and its potential as a drug target or biomarker.

Protein Name: Neurofibromin 1 Pseudogene 1

The "NF1P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NF1P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets